Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis

Ahmed Bettaieb, Kosuke Matsuo, Izumi Matsuo, Naoto Nagata, Samah Chahed, Siming Liu, Fawaz Haj

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The SH2 domain-containing protein-tyrosine phosphatase Src homology phosphatase 2 (Shp2) has been implicated in a variety of growth factor signaling pathways, but its metabolic role in some peripheral insulin-responsive tissues remains unknown. To address the metabolic function of Shp2 in adipose tissue, we generated mice with adipose-specific Shp2 deletion using adiponectin-Cre transgenic mice. We then analyzed insulin sensitivity, glucose tolerance, and body mass in adipose-specific Shp2-deficient and control mice on regular chow and high-fat diet (HFD). Control mice on HFD exhibited increased Shp2 expression in various adipose depots compared with those on regular chow. Adiponectin-Cre mice enabled efficient and specific deletion of Shp2 in adipose tissue. However, adipose Shp2 deletion did not significantly alter body mass in mice on chow or HFD. In addition, mice with adipose Shp2 deletion exhibited comparable insulin sensitivity and glucose tolerance compared with controls. Consistent with this, basal and insulin-stimulated Erk and Akt phosphorylations were comparable in adipose tissue of Shp2-deficient and control mice. Our findings indicate that adipose-specific Shp2 deletion does not significantly alter systemic insulin sensitivity and glucose homeostasis.

Original languageEnglish (US)
Pages (from-to)1193-1201
Number of pages9
JournalMetabolism: Clinical and Experimental
Volume60
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Phosphoric Monoester Hydrolases
Homeostasis
Glucose
High Fat Diet
Insulin Resistance
Adipose Tissue
SH2 Domain-Containing Protein Tyrosine Phosphatases
Insulin
Adiponectin
Metabolic Networks and Pathways
Transgenic Mice
Intercellular Signaling Peptides and Proteins
Phosphorylation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis. / Bettaieb, Ahmed; Matsuo, Kosuke; Matsuo, Izumi; Nagata, Naoto; Chahed, Samah; Liu, Siming; Haj, Fawaz.

In: Metabolism: Clinical and Experimental, Vol. 60, No. 8, 08.2011, p. 1193-1201.

Research output: Contribution to journalArticle

Bettaieb, Ahmed ; Matsuo, Kosuke ; Matsuo, Izumi ; Nagata, Naoto ; Chahed, Samah ; Liu, Siming ; Haj, Fawaz. / Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis. In: Metabolism: Clinical and Experimental. 2011 ; Vol. 60, No. 8. pp. 1193-1201.
@article{bd643aee8eaa4839a169d64cccdeec2d,
title = "Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis",
abstract = "The SH2 domain-containing protein-tyrosine phosphatase Src homology phosphatase 2 (Shp2) has been implicated in a variety of growth factor signaling pathways, but its metabolic role in some peripheral insulin-responsive tissues remains unknown. To address the metabolic function of Shp2 in adipose tissue, we generated mice with adipose-specific Shp2 deletion using adiponectin-Cre transgenic mice. We then analyzed insulin sensitivity, glucose tolerance, and body mass in adipose-specific Shp2-deficient and control mice on regular chow and high-fat diet (HFD). Control mice on HFD exhibited increased Shp2 expression in various adipose depots compared with those on regular chow. Adiponectin-Cre mice enabled efficient and specific deletion of Shp2 in adipose tissue. However, adipose Shp2 deletion did not significantly alter body mass in mice on chow or HFD. In addition, mice with adipose Shp2 deletion exhibited comparable insulin sensitivity and glucose tolerance compared with controls. Consistent with this, basal and insulin-stimulated Erk and Akt phosphorylations were comparable in adipose tissue of Shp2-deficient and control mice. Our findings indicate that adipose-specific Shp2 deletion does not significantly alter systemic insulin sensitivity and glucose homeostasis.",
author = "Ahmed Bettaieb and Kosuke Matsuo and Izumi Matsuo and Naoto Nagata and Samah Chahed and Siming Liu and Fawaz Haj",
year = "2011",
month = "8",
doi = "10.1016/j.metabol.2011.01.004",
language = "English (US)",
volume = "60",
pages = "1193--1201",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis

AU - Bettaieb, Ahmed

AU - Matsuo, Kosuke

AU - Matsuo, Izumi

AU - Nagata, Naoto

AU - Chahed, Samah

AU - Liu, Siming

AU - Haj, Fawaz

PY - 2011/8

Y1 - 2011/8

N2 - The SH2 domain-containing protein-tyrosine phosphatase Src homology phosphatase 2 (Shp2) has been implicated in a variety of growth factor signaling pathways, but its metabolic role in some peripheral insulin-responsive tissues remains unknown. To address the metabolic function of Shp2 in adipose tissue, we generated mice with adipose-specific Shp2 deletion using adiponectin-Cre transgenic mice. We then analyzed insulin sensitivity, glucose tolerance, and body mass in adipose-specific Shp2-deficient and control mice on regular chow and high-fat diet (HFD). Control mice on HFD exhibited increased Shp2 expression in various adipose depots compared with those on regular chow. Adiponectin-Cre mice enabled efficient and specific deletion of Shp2 in adipose tissue. However, adipose Shp2 deletion did not significantly alter body mass in mice on chow or HFD. In addition, mice with adipose Shp2 deletion exhibited comparable insulin sensitivity and glucose tolerance compared with controls. Consistent with this, basal and insulin-stimulated Erk and Akt phosphorylations were comparable in adipose tissue of Shp2-deficient and control mice. Our findings indicate that adipose-specific Shp2 deletion does not significantly alter systemic insulin sensitivity and glucose homeostasis.

AB - The SH2 domain-containing protein-tyrosine phosphatase Src homology phosphatase 2 (Shp2) has been implicated in a variety of growth factor signaling pathways, but its metabolic role in some peripheral insulin-responsive tissues remains unknown. To address the metabolic function of Shp2 in adipose tissue, we generated mice with adipose-specific Shp2 deletion using adiponectin-Cre transgenic mice. We then analyzed insulin sensitivity, glucose tolerance, and body mass in adipose-specific Shp2-deficient and control mice on regular chow and high-fat diet (HFD). Control mice on HFD exhibited increased Shp2 expression in various adipose depots compared with those on regular chow. Adiponectin-Cre mice enabled efficient and specific deletion of Shp2 in adipose tissue. However, adipose Shp2 deletion did not significantly alter body mass in mice on chow or HFD. In addition, mice with adipose Shp2 deletion exhibited comparable insulin sensitivity and glucose tolerance compared with controls. Consistent with this, basal and insulin-stimulated Erk and Akt phosphorylations were comparable in adipose tissue of Shp2-deficient and control mice. Our findings indicate that adipose-specific Shp2 deletion does not significantly alter systemic insulin sensitivity and glucose homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=79960555997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960555997&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2011.01.004

DO - 10.1016/j.metabol.2011.01.004

M3 - Article

C2 - 21353259

AN - SCOPUS:79960555997

VL - 60

SP - 1193

EP - 1201

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 8

ER -